Cardiac Transplant Rejection
9
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
A Study of AI in Cardiac Transplant in Echocardiographic Analysis (ORACLE)
Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues
Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling
A Pilot Study Evaluating the Potential of 18F Fluorodeoxyglucose PET-CT Imaging in Diagnosing Cardiac Rejection.
Quantitative Detection of Circulating Donor-Specific DNA in Organ Transplant Recipients (DTRT-Multi-Center Study)
Outcomes AlloMap Registry: the Long-term Management and Outcomes of Heart Transplant Recipients With AlloMap Testing
Genome Transplant Dynamics: Non-invasive Sequencing-based Diagnosis of Rejection
The "no Biopsy Approach" for Heart Transplantation Follow-up
Home Electrocardiogram (ECG) Monitoring After Heart Transplantation